DOI: 10.36347/sjams.2015.v03i06.015

Pages: 2235-2237

PPI are the most commonly used drugs in clinical practice. Different PPIs do not have any important differences clinically. Reports have estimated that over 60% of all PPI prescriptions are generated from inpatient prescriptions. Cost minimization can only be used to compare two products that have been shown to be equivalent in dose and therapeutic effect. A retrospective cross-sectional study was conducted at the S.S Institute of Medical Science and Research, Davangere. A total of 216 prescriptions containing PPIs of inpatients, were analysed. Data about type of PPI used, brand of PPI, fixed dose combinations, dose and route of administration and their price was noted. Cost minimization study was done. Brands of Pantoprazole like Pantodac, Pantocid, Pantolex, Pantakind and fixed dose combinations like Pan D were prescribed. When compared to the generic versions cost of Pantodac was highest 8.71 times that of generic. Brands of Rabiprazole like Razo Rabicip Rabestar and fixed dose combinations like Rabestar D Rabephex D were prescribed. When compared to the generic versions cost of Razo was highest 6.74 times that of generic followed by Rabicip and Rabestar which was 2.56 times the generic. In conclusion Awareness about prescribing generic drugs and most economic drugs to be created.